Stock NRBO NEUROBO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
4.83 USD +13.38% Intraday chart for NeuroBo Pharmaceuticals, Inc. +25.78% +30.66%
06-26 NeuroBo Pharmaceuticals, Inc. Doses First Patient in the MAD Part 2 of its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity CI
06-26 NeuroBo Pharmaceuticals Raises $20 Million from Share Placement MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROBO PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+13.38%+25.78%+30.66%+54.81% - 23.7M
Bullish
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. NRBO Stock
  4. Charts NeuroBo Pharmaceuticals, Inc.
  5. Relative Strength Chart